Equities

Vo2 Cap Holding AB (publ)

Vo2 Cap Holding AB (publ)

Actions
TechnologyTechnology
  • Price (SEK)6.73
  • Today's Change0.02 / 0.30%
  • Shares traded7.59k
  • 1 Year change-22.38%
  • Beta0.4819
Data delayed at least 15 minutes, as of Jan 31 2023 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Vo2 Cap Holding AB (publ), formerly Curando Nordic AB, is a Sweden-based company, which is engaged in the media tech industry. The Company's business model consists of acquiring and refining entrepreneurial companies.

  • Revenue in SEK (TTM)415.85m
  • Net income in SEK5.98m
  • Incorporated--
  • Employees--
  • Location
    Vo2 Cap Holding AB (publ)Fleminggatan 18STOCKHOLM 112 26SwedenSWE
  • Phone+46 46386741
  • Websitehttps://curando.se/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VO2:STO since
announced
Transaction
value
Borg & Owilli ABDeal completed07 Oct 202207 Oct 2022Deal completed-2.18%10.57m
Livewrapped ABDeal completed21 Apr 202221 Apr 2022Deal completed-21.74%7.19m
Data delayed at least 15 minutes, as of Jan 31 2023 17:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lifecare AS10.71m-18.61m285.05m----12.20--26.61-0.1652-0.16520.09590.19020.4309--2.26---74.86---93.53-------173.74------0.2527---70.34---508.85------
Kancera AB0.00-51.43m285.90m7.00--2.81-----0.7834-0.78340.001.280.00----0.00-42.84-68.54-47.22-86.44--92.88---5,941.59---99.010.00---100.00---12.80------
Moberg Pharma AB (publ)207.00k-16.51m287.45m----0.5224--1,388.64-0.2879-0.28790.00335.460.0004--0.0987---3.32---3.41--100.00---8,036.23-----241.380.0033--------------
SenzaGen AB30.33m-30.94m292.39m16.00--2.98--9.64-1.26-1.261.244.070.28414.465.66---28.98-25.56-32.24-27.4763.32130.22-102.02-471.453.51--0.0092--93.7998.69-15.38---23.45--
Lumito AB (publ)0.00-27.28m292.73m----2.14-----0.2081-0.20810.000.66160.00-------24.84-21.69-25.85-23.38------------0.00-------64.34------
Hamlet Pharma AB0.00-17.20m293.68m4.00--11.89-----0.1569-0.15690.000.34390.00-------63.13-88.40-84.36-115.77-----------226.20---------122.71------
SoftOx Solutions AS7.03m-70.62m294.34m----6.70--41.87-6.55-6.550.6524.070.0992--1.31---99.67-44.89-144.08-54.35-----1,004.63-540.760.2779-130.300.2626---19.69139.15-74.85------
Opticept Technologies AB9.07m-78.69m307.53m----0.6225--33.92-3.59-3.590.412616.550.02120.40341.13---18.51-48.78-20.04-52.0729.73131.87-874.93-840.770.9775-71.810.0701--1,532.35---396.50--54.76--
Lytix Biopharma AS1.47m-45.04m316.60m----1.79--215.56-1.12-1.120.03644.230.0072--0.2655---22.07---23.41-------3,066.50------0.00--466.67---14.16------
Initiator Pharma A/S0.00-60.99m328.41m----5.87-----1.28-1.280.001.070.00-------74.43-70.46-78.10-80.40------------0.2643-------142.20------
Abliva AB79.00k-104.56m344.88m8.00--1.90--4,365.59-0.2269-0.22690.00020.17210.0005--0.00179,875.00-68.89-67.30-80.31-79.05-----132,358.20-76,095.50---35.460.00---30.0960.91-105.86---43.06--
Vo2 Cap Holding AB (publ)415.85m5.98m345.88m--55.071.8317.860.83180.12180.12188.653.661.47--8.15--2.12-31.873.07-57.9522.3426.641.44-19.29--5.200.1549--46,310.78185.46-246.86------
Biovica International AB2.90m-77.64m360.36m27.00--3.22--124.18-2.69-2.690.10072.840.0213-1.826.01116,080.00-56.94-30.85-62.19-33.47179.12332.81-2,675.53-1,470.093.20-423.610.1315---1.5426.47-51.97------
Cereno Scientific AB0.00-23.25m375.42m----1.37-----0.2209-0.22090.002.000.00-------10.95-18.58-11.93-20.82-----------27.720.025-------1.48--54.51--
Alligator Bioscience AB20.88m-176.94m401.46m55.00--2.83--19.22-1.11-1.110.11290.64210.124--2.06453,978.30-105.05-33.26-145.40-36.20-----847.30-672.07----0.1175--197.40-25.981.09---58.36--
Exact Therapeutics AS0.00-60.44m406.50m8.00--2.87-----2.71-2.710.004.52------0.00--------------------0.0137-------123.18------
Data as of Jan 31 2023. Currency figures normalised to Vo2 Cap Holding AB (publ)'s reporting currency: Swedish Krona SEK
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.